The CenterWatch Weekly, October 24, 2016
UK group launches OpenTrials transparency site, U.S. experts keep an open mind
Open Knowledge, a nonprofit dedicated to creating and sharing medical information, has launched a Beta version of its OpenTrials online search engine of the world’s clinical trials. According to Open Knowledge, the OpenTrials site features an advanced “threading” search function to aid comparison data and promote transparency. The site will also allow users to highlight important discrepancies in data.
CluePoints, a provider of risk-based monitoring and data quality oversight software, has signed a Cooperative Research and Development Agreement (CRADA) with the FDA. By signing the agreement, the FDA will be able to develop and test CluePoints’ existing quality oversite software, further exploring a data-driven approach to identify clinical trial sites that exhibit anomalies that may indicate signs of fraud or misconduct. The FDA anticipates the approach will help identify sites that may have escaped detection previously, accelerate a more rapid turnaround of results, offer the ability to determine the nature and extent of data anomalies, and provide means of exploring the interaction of various factors with data quality.
To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.